Capitolis Liquid Global Markets LLC Abb Vie Inc. Transaction History
Capitolis Liquid Global Markets LLC
- $12.3 Billion
- Q3 2025
A detailed history of Capitolis Liquid Global Markets LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Capitolis Liquid Global Markets LLC holds 591,071 shares of ABBV stock, worth $138 Million. This represents 1.11% of its overall portfolio holdings.
Number of Shares
591,071
Previous 642,300
7.98%
Holding current value
$138 Million
Previous $119 Billion
99.89%
% of portfolio
1.11%
Previous 0.87%
Shares
7 transactions
Others Institutions Holding ABBV
# of Institutions
4,489Shares Held
1.28BCall Options Held
16.9MPut Options Held
15.2M-
Vanguard Group Inc Valley Forge, PA178MShares$41.6 Billion0.64% of portfolio
-
Black Rock Inc. New York, NY136MShares$31.9 Billion0.54% of portfolio
-
State Street Corp Boston, MA79.8MShares$18.7 Billion0.66% of portfolio
-
Jpmorgan Chase & CO New York, NY56.5MShares$13.2 Billion0.86% of portfolio
-
Morgan Stanley New York, NY41.7MShares$9.75 Billion0.61% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $414B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...